[HTML] scielo.br

[HTML][HTML] Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

IS Maia, MP Pincelli, VF Leite, J Amadera… - Jornal Brasileiro de …, 2017 - SciELO Brasil
Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD …
被引用次数：17 相关文章

Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis.

IS Maia, MP Pincelli, VF Leite, J Amadera… - Jornal Brasileiro de …, 2017 - europepmc.org
Objective To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD …
[HTML] bvsalud.org

[HTML][HTML] Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

IS Maia, MP Pincelli, VF Leite, J Amadera… - J. bras …, 2017 - pesquisa.bvsalud.org
Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD …

Long-acting muscarinic antagonists vs. long-acting β

IS Maia, MP Pincelli, VF Leite, J Amadera… - J Bras …, 2017 - SciELO Brasil
Long-acting muscarinic antagonists vs. long-acting β agonists in COPD exacerbations: a
systematic review and meta-analysis Page 1 ISSN 1806-3713 © 2017 Sociedade Brasileira de …
[PDF] academia.edu

[PDF][PDF] Long-acting muscarinic antagonists vs. long-acting β

IS Maia, MP Pincelli, VF Leite, J Amadera… - J Bras …, 2017 - academia.edu
Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD …
[PDF] semanticscholar.org

[PDF][PDF] Long-acting muscarinic antagonists vs. long-acting β

IS Maia, MP Pincelli, VF Leite, J Amadera… - J Bras …, 2017 - pdfs.semanticscholar.org
Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD …

Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

IS Maia, MP Pincelli, VF Leite… - Jornal brasileiro de …, 2017 - pubmed.ncbi.nlm.nih.gov
Objetivo: Determinar se long-acting muscarinic antagonists (LAMAs, antagonistas
muscarínicos de longa duração) são superiores a long-acting β 2 agonists (LABAs, β 2 …
[PDF] usp.br

[PDF][PDF] Long-acting muscarinic antagonists vs. long-acting β

IS Maia, MP Pincelli, VF Leite, J Amadera… - J Bras …, 2017 - observatorio.fm.usp.br
Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD …
[PDF] scienceopen.com

[PDF][PDF] Long-acting muscarinic antagonists vs. long-acting β

IS Maia, MP Pincelli, VF Leite, J Amadera… - J Bras …, 2017 - scienceopen.com
Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β2 agonists (LABAs) for preventing COPD …
[HTML] nih.gov

[HTML][HTML] Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis

IS Maia, MP Pincelli, VF Leite, J Amadera… - Jornal Brasileiro de …, 2017 - ncbi.nlm.nih.gov
Objective: To determine whether long-acting muscarinic antagonists (LAMAs) provide
superior therapeutic effects over long-acting β 2 agonists (LABAs) for preventing COPD …